CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Key Biotech Applications In Agriculture

Key Biotech Applications In Agriculture

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Tryp Therapeutics Breaks New Grounds in Investigational Drugs

Tryp Therapeutics Breaks New Grounds...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

Key Biotech Applications In Agriculture

Key Biotech Applications In Agriculture

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Tryp Therapeutics Breaks New Grounds in Investigational Drugs

Tryp Therapeutics Breaks New Grounds...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

Aquestive and IntelGenx Join Hands with Mens Health Company to Increase Market for Tadalafil Oral Films

Life Sciences Review Life Sciences Review | Monday, October 25, 2021
Tweet

Aquestive Therapeutics has signed a license and supply agreement with a leading men’s health company to make Tadalafil oral films available to men suffering from erectile dysfunction.


FREMONT, CA: “Securing this commercial partnership is a significant milestone in our innovative collaboration with Aquestive and represents another major step toward achieving our mutual goal of making Tadalafil oral films available to men suffering from ED and BPH,” states Dr. Horst G. Zerbe, CEO of IntelGenx. Aquestive Therapeutics, Inc., IntelGenx Corp.'s co-development and commercialization partner for Tadalafil oral films for the treatment of erectile dysfunction (ED) and benign prostatic hyperplasia (BPH) (the Product), has signed a definitive license and supply agreement with an undisclosed leading men's health company.


Aquestive Therapeutics is a pharmaceutical company that uses cutting-edge technology to solve therapeutic issues and improve patient care. To date, the company has only commercialized one internally-developed proprietary product, Sympazan® oral film, but it has a commercial proprietary product pipeline focused on the treatment of central nervous system diseases and other unmet needs, and it is developing orally-administered complex molecules as alternatives to invasively administered standard of care therapies. 


The company also works with other pharmaceutical companies to bring new compounds to market utilizing proprietary, best-in-class technologies, and it has demonstrated medication development and commercialization skills.


IntelGenx is a renowned drug delivery firm that specializes in pharmaceutical film research and production. VersaFilm®, DisinteQ, VetaFilm, and transdermal VevaDerm, among IntelGenx's excellent film technologies, enable next-generation pharmaceutical products to solve unmet medical requirements. For a variety of therapeutic situations, IntelGenx's breakthrough product pipeline provides considerable benefits to patients and physicians. IntelGenx's highly qualified staff provides pharmaceutical partners with a full range of services, including R&D, analytical method development, clinical monitoring, intellectual property, and regulatory services. IntelGenx's cutting-edge manufacturing facility provides a comprehensive range of services, from lab to pilot to commercial-scale production.


Weekly Brief

loading
Top 10 Leading BioTech Solution Companies - 2021
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/aquestive-and-intelgenx-join-hands-with-mens-health-company-to-increase-market-for-tadalafil-oral-films-nwid-601.html